6-KThe Wire
GSK plc files 6-K
Filed Jun 9, 2026 · 24d ago · Accession 0001654954-26-005819
Plain English
GSK plc announced that Dr. Hal Barron, a Non-Executive Director, was appointed as an Independent Director and Chair of the Nominating and Corporate Governance Committee of Quantinuum Inc. on June 4, 2026. This appointment was made in accordance with UK Listing Rule 6.4.9R(2).
Filing details
- Company
- GSK plc
- Ticker
- GSK
- CIK
- 1131399
- Form type
- 6-K
- Filing date
- Jun 9, 2026
- Report date
- Jun 9, 2026
- Document
- a6477h.htm
- Size
- 19 KB